ResMed Q4 FY26: where the revenue came from and where it went
The whole income statement of ResMed for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Aug 13, 2026
Revenue$1.46B
+9% year over year
Gross profit$0.86B
59% margin
Operating profit$0.45B
31% margin
Net profit$0.38B
26% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.46 | 100% | +9% |
| Sleep & breathing health | 1.26 | 86% | |
| Residential care software | 0.17 | 12% | |
| Other revenue | 0.03 | 2% | |
| Cost of revenue | −0.60 | 41% | |
| Gross profit | 0.86 | 59% margin | −2pp |
| R&D | −0.11 | 7% | +1pp |
| SG&A | −0.30 | 20% | +0pp |
| Other | −0.01 | 1% | +0pp |
| Operating profit | 0.45 | 31% margin | −3pp |
| Other income, net | 0.03 | ||
| Tax | −0.09 | ||
| Net profit | 0.38 | 26% margin | −2pp |
51 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest